Victor O. Gawriljuk - Concepedia

Author

Victor O. Gawriljuk

Also Known As

Gabriela Dias Noske, Gawriljuk, Victor O., Robert Glen, V. O. Gawriljuk, V.O. Gawriljuk, Victor O. Gawriljuk, Victor Oliveira Gawriljuk

Publications

975

Citations

H-Index

Concepts

All Affiliations

Universidade de São Paulo Collaborations Pharmaceuticals (United States)Institute of Physics Diamond Light Source MAX IV Laboratory

About

Victor O. Gawriljuk is an author at Universidade de São Paulo specializing in medicine, microbiology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	43
2	Microbiology	2	2	43
3	Molecular Biology	1	1	18
4	Pharmacology	1	1	25
5	Structural Biology	1	1	18

Victor O. Gawriljuk

Publications

589

Citations

H-Index

Page 1

	Year	Citations
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors Melissa L. Boby, D. Fearon, Matteo P. Ferla, Science	2023	158
Quantum Machine Learning Algorithms for Drug Discovery Applications Kushal Batra, Kimberley M. Zorn, Daniel H. Foil, Journal of Chemical Information and Modeling	2021	149
Machine Learning Models Identify Inhibitors of SARS-CoV-2 Victor O. Gawriljuk, Phyo Phyo Kyaw Zin, Ana C. Puhl, Journal of Chemical Information and Modeling	2021	50
Non-Toxic Dimeric Peptides Derived from the Bothropstoxin-I Are Potent SARS-CoV-2 and Papain-like Protease Inhibitors Marjorie C. L. C. Freire, G.D. Noske, Natália Vitória Bitencourt, Molecules	2021	35
Development of Machine Learning Models and the Discovery of a New Antiviral Compound against Yellow Fever Virus Victor O. Gawriljuk, Daniel H. Foil, Ana C. Puhl, Journal of Chemical Information and Modeling	2021	28
Pyronaridine Protects against SARS-CoV-2 Infection in Mouse Ana C. Puhl, Giovanni Freitas Gomes, Samara Damasceno, ACS Infectious Diseases	2022	28
Discovery of an imidazonaphthyridine and a riminophenazine as potent anti-Zika virus agents through a replicon-based high-throughput screening R.S. Fernandes, André S. Godoy, Igor Andrade Santos, Virus Research MedicineAntiviral TherapyVirologyReplicon-based High-throughput ScreeningMicrobiology	2021	25
Turning high-throughput structural biology into predictive inhibitor design Kadi L. Saar, William McCorkindale, D. Fearon, Proceedings of the National Academy of Sciences	2023	22
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease André S. Godoy, A.M. Nakamura, A. Douangamath, Nucleic Acids Research	2023	21
First crystal structures of 1-deoxy-d-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization Robin M. Gierse, Rick Oerlemans, Eswar R. Reddem, Scientific Reports	2022	19

Page 1